MIR6735: A Promising Drug Target and Biomarker (G102465440)
MIR6735: A Promising Drug Target and Biomarker
MIR6735 (hsa-miR-6735-5p) is a microRNA (miRNA) that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its unique structure and specificity make it an attractive target for researchers to study and develop new treatments.
MIR6735 is a non-coding RNA molecule that contains 61 amino acid residues. It is expressed in various tissues and organs, including the brain, heart, liver, and muscle. It is primarily expressed in the brain and has been shown to be involved in the development and progression of several neurological diseases, including Alzheimer's disease, Parkinson's disease, and neurodegenerative disorders.
One of the reasons why MIR6735 has drawn attention is its potential as a drug target. The miRNA pathway is a well-established system for drug development, as many drugs that are currently on the market work by targeting miRNAs. By inhibiting the activity of MIR6735, researchers can potentially reduce the risk of developing neurodegenerative diseases.
Another potential application of MIR6735 is as a biomarker for cancer. The expression of MIR6735 has been observed in various types of cancer, including breast, lung, and ovarian cancer. Researchers have also shown that MIR6735 can be downregulated in cancer cells, which suggests that targeting this miRNA may be a promising strategy for cancer treatment.
In addition to its potential drug and biomarker applications, MIR6735 also has important structural features that make it an attractive target for study. Its unique sequence and composition make it difficult to predict the structure and activity of a related molecule. This uncertainty makes it an ideal candidate for drug development, as researchers can use MIR6735 as a starting point to develop new treatments without knowing the full extent of its potential benefits.
Overall, MIR6735 is a promising drug target and biomarker for various diseases. Its unique structure and specificity make it an attractive candidate for further study and development. As research continues to advance, we can expect to see new treatments and therapies based on MIR6735 and its related miRNAs.
Protein Name: MicroRNA 6735
More Common Targets
MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787 | MIR6788 | MIR6789 | MIR6790 | MIR6791 | MIR6792 | MIR6793 | MIR6794 | MIR6795 | MIR6796 | MIR6797 | MIR6798 | MIR6799 | MIR6800 | MIR6801 | MIR6802 | MIR6803 | MIR6804 | MIR6805 | MIR6806 | MIR6807 | MIR6808 | MIR6809 | MIR6810 | MIR6811 | MIR6812 | MIR6813 | MIR6814 | MIR6815 | MIR6816 | MIR6817 | MIR6818 | MIR6819 | MIR6820 | MIR6821 | MIR6822 | MIR6823 | MIR6824 | MIR6825 | MIR6826 | MIR6827 | MIR6828 | MIR6829 | MIR6830
